Wolbachia-Mediated Resistance to Dengue Virus Infection and Death at the Cellular Level by Frentiu, Francesca D. et al.
Wolbachia-Mediated Resistance to Dengue Virus
Infection and Death at the Cellular Level
Francesca D. Frentiu
1, Jodie Robinson
2, Paul R. Young
2, Elizabeth A. McGraw
1, Scott L. O’Neill
1*
1School of Biological Sciences, The University of Queensland, Brisbane, Australia, 2Centre for Infectious Disease Research, School of Chemistry and Molecular Biosciences,
The University of Queensland, Brisbane, Australia
Abstract
Background: Dengue is currently the most important arthropod-borne viral disease of humans. Recent work has shown
dengue virus displays limited replication in its primary vector, the mosquito Aedes aegypti, when the insect harbors the
endosymbiotic bacterium Wolbachia pipientis. Wolbachia-mediated inhibition of virus replication may lead to novel
methods of arboviral control, yet the functional and cellular mechanisms that underpin it are unknown.
Methodology/Principal Findings: Using paired Wolbachia-infected and uninfected Aedes-derived cell lines and dengue
virus, we confirm the phenomenon of viral inhibition at the cellular level. Although Wolbachia imposes a fitness cost to cells
via reduced proliferation, it also provides a significant degree of protection from virus-induced mortality. The extent of viral
inhibition is related to the density of Wolbachia per cell, with highly infected cell lines showing almost complete protection
from dengue infection and dramatically reduced virus titers compared to lines not infected with the bacteria.
Conclusions/Significance: We have shown that cells infected with Wolbachia display inhibition of dengue virus replication,
that the extent of inhibition is related to bacterial density and that Wolbachia infection, although costly, will provide a
fitness benefit in some circumstances. Our results parallel findings in mosquitoes and flies, indicating that cell line models
will provide useful and experimentally tractable models to study the mechanisms underlying Wolbachia-mediated
protection from viruses.
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Introduction
Dengue is the most important arthropod-borne viral disease
currently affecting human populations. The severity and frequency
of dengue outbreaks is rapidly increasing across the world and the
geographic range of the virus is expanding from the tropics into
more temperate areas [1,2,3]. Dengue fever and its often lethal
complication, dengue hemorrhagic fever, have become the leading
arboviral causes of illness and death in recent years [3,4]. Dengue
virus (DENV) is transmitted to humans by Aedes mosquitoes, with
the most important vectors being Aedes aegypti and, to a lesser
extent, Aedes albopictus. The absence of either a vaccine or
therapeutic strategies against all four DENV (DENV 1–4)
serotypes has reinforced the need for improved approaches to
control vector populations.
Infection of mosquitoes with the maternally inherited bacterial
endosymbiont Wolbachia pipientis has been proposed as a novel
strategy to modify mosquito populations and their subsequent
ability to transmit pathogens [5]. Wolbachia infection of mosquitoes
may reduce transmission of DENV in several ways. Aedes aegypti
females infected with the wMelPop-CLA strain of Wolbachia have
dramatically reduced life spans [6]. Eliminating older mosquitoes
in a population may break the transmission cycle of DENV since
the virus requires 7–14 days to complete its extrinsic incubation
period in the vector, a period representing a substantial proportion
of the mosquito lifespan [7]. Importantly, Wolbachia infected
mosquitoes also show reduced vector competence [8] and reduced
replication of dengue virus [8,9], Chikungunya virus [8,9],
Plasmodium [8] and filarial nematodes [10]. More generally,
Drosophila melanogaster flies infected with Wolbachia show significant-
ly reduced replication of RNA viruses [11,12], with this effect
strongest in Wolbachia strains most closely related to the strain
wMelPop [13].
Wolbachia-induced resistance to RNA virus infection in insects
may provide us with a powerful way to control insect-transmitted
diseases yet the cellular and molecular mechanisms that underpin
resistance remain unknown. Wolbachia may induce priming of
insect defense genes prior to virus infection [8,9,10,14]. A range of
immune genes was found to be upregulated in wMelPop-CLA
infected versus uninfected mosquitoes [8,10], as well as in Aedes
aegypti infected with a different Wolbachia strain, wAlbB [9].
Alternatively, Wolbachia may directly interfere with virus replica-
tion at the cellular level and/or may directly or indirectly compete
for host resources [8,14] since both bacteria and virus require the
same environment (the cytoplasm) in which to replicate
[15,16,17]. Spatial exclusion of DENV from Wolbachia-infected
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microscopy of mosquito sections [8].
Understanding the mechanism of viral inhibition using whole
organisms is complicated by Wolbachia density differences among
various tissues [8,15] and the dynamic nature of these infections
[16,18]. In addition, the insect host genetic background, age and
environment also have a significant effect on Wolbachia infection
levels [19,20,21]. By contrast, cell line models circumvent many of
these complications, as well as being more experimentally
tractable. Examining the interaction between Wolbachia and
DENV in mosquito cell lines will determine whether they provide
good models for dissecting the mechanistic basis of viral inhibition.
Here, we explored the replication dynamics of the New Guinea
C strain of DENV serotype 2 (DENV-2) in two sets of paired
Wolbachia-infected and uninfected mosquito cell lines, RML12 and
C6/36, both originally from Aedes albopictus. The C6/36 line was
stably infected with the wMelPop-CLA strain, that had been
previously adapted to RML12 cells over the course of more than
250 passages. Both cell lines displayed almost 100% infection with
Wolbachia but they differed dramatically in the density of bacteria
per cell. Although Wolbachia infection had a negative effect on cell
proliferation, suggesting a heavy metabolic cost it also conferred a
significant degree of protection against DENV-2 induced cyto-
pathic effects. DENV-2 replication was dramatically reduced in
both Wolbachia-infected lines compared to uninfected controls,
with an almost complete absence of viral replication in the cell line
most densely infected with Wolbachia.
Results
Wolbachia infection and density in two insect cell lines
We used the Aedes albopictus [22] RML12 cell line previously
infected with wMelPop-CLA [23] (here termed RML12.wMelPop-
CLA; Figure 1A). A control Wolbachia uninfected RML12 line,
named RML12.Tet, was obtained after three rounds of tetracy-
cline treatment, as checked by fluorescent in situ hybridization
(FISH) and PCR. The Ae. albopictus cell line C6/36, routinely used
in DENV studies, was also infected with wMelPop-CLA purified
from the RML12.wMelPop-CLA using a modified shell vial
technique [24]. By passage 6, 100% (60% s.e.) of cells counted in
the C6/36.wMelPop-CLA line, visualized using FISH, were
infected with Wolbachia. Stable infection with wMelPop-CLA
remained at 100% throughout the course of the experiments, as
verified by FISH (Figure 1B). Wolbachia infection rates in the
Figure 1. Wolbachia infections in the RML12.wMelPop-CLA (A) and C6/36.wMelPop-CLA (B) cell lines, visualized using fluorescent in
situ hybridization (FISH) with Wolbachia-specific probes. Wolbachia bacteria are shown in red and cell nuclei are shown in blue (stained with
DAPI). (C) Differences in the absolute density of Wolbachia per cell between the RML12.wMelPop-CLA and C6/36.wMelPop-CLA lines. Box and whisker
plots display medians and 5 and 95 percentiles of five replicate pools of 2.56105 cells/line (*** p,0.001 by t-test).
doi:10.1371/journal.pone.0013398.g001
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(61.59% s.e.), based on counts of cells visualized using FISH.
Next, we examined the density of Wolbachia per cell in the two
infected cell lines by first examining the ratio of number of copies
of the wsp (Wolbachia surface protein) gene relative to the mosquito
reference gene RpS17 [7] using quantitative PCR (qPCR). Because
some cell lines have altered levels of ploidy [25] and it cannot be
assumed that reference genes are represented by single copies, we
also quantified the absolute number of copies of the wsp gene by
qPCR [8]. A significant difference in Wolbachia density between
cell lines was found by examining the expression of the wsp gene
relative to the expression of the mosquito housekeeping gene
RpS17 [7] (Wilcoxon rank sum test W=25, p=0.008). Quanti-
fication of the absolute, rather than relative, number of copies of
the wsp gene also showed that the C6/36.wMelPop-CLA line had,
on average, significantly more bacteria per cell than the
RML12.wMelPop-CLA line (t=11.5751, df=8, p,0.001). The
average density of Wolbachia per cell in the C6/36.wMelPop-CLA
line was approximately three times higher than the density in the
RML12.wMelPop-CLA line (Figure 1C).
Wolbachia-infected cells proliferate slowly but resist
DENV-induced mortality
The wMelPop-CLA strain dramatically reduces mosquito fitness
through reduction in lifespan [6] and impaired probing and
feeding [26,27]. We investigated whether cells infected with
wMelPop-CLA also displayed reduced fitness by assaying cell
proliferation at 4 time points over the course of 8 days. Both
Wolbachia-infected cell lines showed reduced cell proliferation
compared to uninfected cell lines (Figure 2), although to differing
extents. In the RML12.wMelPop-CLA cell line, cell proliferation
was particularly low by day 2 (Figure 2A). However, by day 4 post-
infection, RML12.wMelPop-CLA cells had recovered and closely
followed the proliferation pattern of RML12.Tet cells. Cells from
the C6/36.wMelPop-CLA line displayed a dramatically lower rate
of proliferation compared to C6/36 cells at all four time points,
suggesting a sustained metabolic cost to Wolbachia infection
(Figure 2B).
Next, we investigated the effect of Wolbachia infection on
proliferation when cells were also infected with DENV-2. At days
6 and 8, RML12.Tet cells that are infected with DENV-2
Figure 2. Cell proliferation of the RML12.wMelPop-CLA (A) and C6/36.wMelPop-CLA (B) lines at days 2, 4, 6 and 8 after infection
with DENV-2 (NGC strain) or mock infection (no DENV-2). Bars indicate means 6 SEM of absorbance measurements from 8 replicate wells.
doi:10.1371/journal.pone.0013398.g002
Wolbachia Inhibits Dengue
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13398proliferate far more slowly than RML12.wMelPop-CLA that are
also infected with virus (Figure 2A). Two-way ANOVA results for
each day indicated that dual infection with Wolbachia and DENV
significantly impacted on cell proliferation only on days 6 and 8
(day 6: SS=0.22, F1, 28=13.63, P=0.001; day 8: SS=0.48,
F1, 28=10.86, P=0.003). A more dramatic reduction in cell
proliferation was found for the C6/36 cells infected with DENV-2
when compared to virus infected C6/36.wMelPop-CLA cells
(Figure 2B). Interestingly, the degree of proliferation in the C6/
36.wMelPop-CLA cells was the same regardless of whether they
were infected with DENV-2 or not, suggesting virus infection had
no effect on Wolbachia-infected cells. By contrast, DENV-2
infection had a significant negative effect on cell proliferation in
the C6/36 line only, at days 4, 6 and 8 post-infection (day 4:
SS=0.01, F1, 27=28.55, P,0.001; day 6: SS=0.18, F1, 22=
45.94, P,0.001; day 8: SS=0.42, F1, 27=124, P,0.001). In
summary, although both C6/36.wMelPop and RML12.wMelPop
lines experienced reduced cell proliferation compared to Wolba-
chia-uninfected counterparts, they were afforded a significant
degree of protection from costs associated with DENV-2 infection.
Reduced DENV-2 replication in Wolbachia-infected versus
uninfected cells
We next tested whether Wolbachia-infected cells showed reduced
replication of DENV-2, as has been found in mosquitoes [8,9].
Viral replication was dramatically reduced in both RML12.wMel-
Pop-CLA and C6/36.wMelPop-CLA cell lines compared to lines
not carrying Wolbachia (Figure 3), based on estimates of titer from
virus harvested at days 2, 4, 6 and 8 post-infection. In
RML12.wMelPop-CLA, at the three multiplicities of infection
(MOIs) of 0.1, 1 and 5, and across all days sampled, viral titer was
reduced by at least 1 log compared to RML12.Tet (Figure 3A;
Figure 3. Viral replication of DENV-2 (NGC strain) in the RML12.wMelPop-CLA (A) and C6/36.wMelPop-CLA (B) cell lines harvested
on days 2, 4, 6 and 8 post-infection, at multiplicities of infection of 0.1 and 5 (data for MOI 1 not shown). Bars indicate means 6 SEM of
viral titer from 3 replicate wells.
doi:10.1371/journal.pone.0013398.g003
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MOI, wMelPop-CLA had a strong inhibitory effect on virus
growth. Although viral titer was markedly reduced, the inhibitory
effect was not complete. By day 8 post-infection, at the low MOI
of 0.1, at least 4.2 log pfu/ml was being produced in the
RML.wMelPop-CLA cells (Figure 3A). ANOVA results indicated
that Wolbachia infection, day post-infection and initial MOI all had
highly significant but complex and interacting effects on viral titer
(results not shown), with the largest effect due to the presence or
absence of Wolbachia. Two-sample t-tests indicated that Wolbachia
had a highly significant effect on viral output each day (day 2:
t=14.064, p,0.001; day 4: t=10.799, p,0.001; day 6:
t=22.185, p,0.001; day 8: t=11.214, p,0.001).
Viral titer in the C6/36.wMelPop-CLA line was even more
dramatically reduced compared to the C6/36 control line, with
the highest titer produced by Wolbachia-infected cells being
100 pfu/ml (Figure 3B; data for MOI 1 not shown). Although at
an MOI of 5 virus particles were detected across all harvest points
in the C6/36.wMelPop-CLA line, at the low MOI of 0.1 no
infectious particles were detected at all for days 4 and 6 post-
infection (Figure 3B). Results from Wilcoxon rank sum tests
indicated Wolbachia had a highly significant effect on viral titer for
all four days post-infection that were sampled (all p-values
,0.001). The highest amount of infectious virus was found at
day 2 post-infection, suggesting detection of a few virus particles
remaining from the initial inoculum or that a number of particles
had escaped the inhibitory effect of Wolbachia. The first
explanation is most likely since under the second hypothesis a
steady increase in virus from days 4 to 8 would be expected rather
than the decline observed (Figure 3B).
Discussion
We have shown that infection of insect cells in culture with
Wolbachia resulted in reduced host cell proliferation but afforded
greater survival to cells when they were challenged with DENV-
2. Wolbachia infection here had a negative effect on host cell
replication, probably due to this obligate bacterium’s need for
host resources [28] and the high densities to which the wMelPop
strain replicates in flies and mosquitoes [8,18,21,23]. Reduced
cell replication was particularly pronounced in the C6/
36.wMelPop-CLA line, which harbored on average three times
more bacteria per cell than the RML12.wMelPop-CLA line.
However our results also showed, for both cell lines, that when
dengue virus was introduced into the system, it became beneficial
for cells to host Wolbachia due to increased survival. The results
parallel the findings of Bian et al. 2010 [9] at the whole organism
level where Wolbachia-infected female mosquitoes survived
DENV-2 infection longer than uninfected females. Our results
add to the growing body of evidence that, although Wolbachia
infection imposes a metabolic cost that can lead to lowered host
fitness, in certain circumstances, such as viral infections
[11,12,14] and nutritional stress [29], these bacteria also provide
a fitness benefit.
Infection with Wolbachia resulted in significantly lowered viral
replication in the two mosquito cell lines compared to uninfected
controls. Our results parallel those found in whole organisms,
whereby Wolbachia-infected flies [11,12,13] and mosquitoes [8,9]
showed decreased replication of a range of RNA viruses. The same
phenotype (a reduction in viral output) is observed at both the
organismal and cellular levels, suggesting that the cell line models
we have developed here will be useful in dissecting the functional
basis of Wolbachia-mediated antiviral protection. Although cell line
models infected with other strains of Wolbachia exist (e.g. wAlbB in
Ae. albopictus Aa23 cells [30]; wMel in Aa23 and C6/36 cells, [22]),
it is unclear whether the same pattern of viral inhibition has been
observed. DENV-2 replication was reduced in both cell lines
infected with wMelPop-CLA, however, the extent of the reduction
was highest in the line most densely infected with Wolbachia, C6/
36.wMelPop-CLA. Viral titers in this line were dramatically
reduced by almost four logs, to almost complete absence for the
lowest MOI of 0.1. The difference in viral output suggests that the
density of bacteria per cell may have had a significant effect on the
extent of viral inhibition.
Previous work utilizing Drosophila simulans has suggested that
Wolbachia strains that grow to high density provide the highest
protection from virus infection [13]. It remained unclear, however,
if this relationship was due to the density of Wolbachia or the
phylogenetic history of those strains, which were most closely
related to wMel [13]. Our simpler, more homogenous cell line
models indicate that differing densities of the same Wolbachia strain
can modulate the extent of viral infection, with more densely
infected cells displaying the strongest DENV-2 inhibition. These
results favor the hypothesis that viral inhibition may be due to
competition between Wolbachia and DENV-2 for host cellular
resources [8,14].
The reason for Wolbachia density differences between the two
cells lines is unclear, although a similar pattern has been observed
in RML12 and C6/36 cells infected with the wMel Wolbachia
strain [22]. It may be due to differences in host genetic
background between the cell lines and/or the longer time since
the initial establishment of Wolbachia infection (263 passages) for
the RML12.wMelPop-CLA compared to the C6/36.wMelPop-
CLA line (18 passages). Previous research has shown that although
the wMelPop strain replicates to unusually high densities in host
tissues [8,16] its virulence attenuates under strong selection
[18,23]. Further work will be required to determine whether the
C6/36.wMelPop-CLA line will retain a high density of Wolbachia
during future passages and continue to display the same extent of
viral inhibition.
Previous work has indicated exclusion of DENV-2 from both
mosquito tissues and cells that were infected with wMelPop-CLA
[8]. Our results suggested that exclusion of DENV-2 most likely
occurred only in the very densely Wolbachia-infected line C6/
36.wMelPop-CLA. Proliferation data showed that infection with
DENV-2 had absolutely no effect on the replication of C6/
36.wMelPop-CLA cells, suggesting a complete absence of viral
replication. However, presence of viral titer in the RML12.wMel-
Pop-CLA suggests that DENV-2 was also present in the cells that
were infected with Wolbachia. It is unlikely that DENV-2 was
replicating in a subset of cells uninfected with Wolbachia in the line
RML12.wMelPop-CLA since FISH analyses established that there
was almost 100% Wolbachia infection in both cell lines. In addition,
Wolbachia of a different strain was found to co-localize with
Japanese encephalitis virus particles in the salivary glands of the Ae.
albopictus mosquito [31].
Previous work has shown that Wolbachia-infected mosquitoes
display priming of immune system genes, possibly underpinning
viral inhibition [8,9,10]. Arboviral infection in mosquitoes and
some mosquito cell lines induces antimicrobial immune pathways
such as Toll, JAK/STAT and Imd/JNK [32,33] as well as RNAi-
based defenses [34]. Some immune pathways, such as Toll and
Imd/JNK, are also activated in Drosophila cell lines infected with
Wolbachia [35]. Pre-activation of Imd in particular has been shown
to inhibit Semliki Forest virus replication in a mosquito cell line
[32]. However, recent work has suggested that pre-activation of
immune genes by E. coli challenge has no impact on DENV-2
replication in a mosquito cell line [36]. The cell line models
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Wolbachia stimulates the same immune pathways that modulate
DENV-2 infection [36]. Our finding that viral inhibition in cell
lines parallels that observed in whole insects allows us to study the
role of immunity in this simpler model without the complexity of
tissue and organ-specific expression of immune response found in
whole insects [33,34].
In summary, we have shown that cells infected with Wolbachia
display inhibition of dengue virus replication, that the extent of
inhibition is most likely related to bacterial density and that
Wolbachia infection will provide a fitness benefit in some
circumstances despite significant metabolic costs to the mosquito
cell. Our results parallel those observed at the level of the whole
organism, indicating that cell lines will provide useful models to
examine the functional basis of Wolbachia-mediated viral inhibition
and facilitate the development of novel vector control methods for
insect-borne pathogens.
Materials and Methods
Cell line maintenance and Wolbachia infection
We used an RML12 cell line previously infected in 2007 with
wMelPop-CLA [23]. A paired Wolbachia-free line, designated
RML12.Tet, was derived by treating cells with 1 mg/ml tetracycline
for 3 passages, followed by an additional 3 passages without antibiotic
before the start of the experiment. RML12.wMelPop-CLA and
RML12.Tet cells were routinely grown and passaged as in [23].
Absence of Wolbachia in the RML12.Tet line was confirmed by PCR
and by fluorescent in situ hybridization (FISH). For PCR, cells were
harvested at each of 4 passages post-tetracycline treatment in 2 x STE
[0.2 M NaCl, 20 mM Tris-HCl and 2 mM EDTA (pH 8.0)]
containing 0.8 mg/ml Proteinase K, incubated at 56uC for 30 min
and 100uC for 15 min and followed by centrifugation at 13000 rpm
for 2 min. Two ml of the supernatant were used for PCR as in [23].
For FISH, cells were grown to ,80% confluence on chambered
NUNC slides (Invitrogen), washed twice with PBS buffer and fixed
for 15 min in 4% formaldehyde in PBS. Slides were then washed 3
times for 5 min with 0.1 M phosphate buffer (PB) and incubated with
100% EtOH for 5 min. Hybridization was performed using the
wMelPop-specific 16s rRNA probes W2 and W3 [8]. Visualization
was performed with a Zeiss Axioscope epifluorescence microscope.
C6/36 cells were infected with wMelPop-CLA obtained from
the RML12.wMelPop-CLA line (above). Wolbachia were purified
from confluent cells grown in four 175-cm
2 by two rounds of
centrifugation at 1000 g for 10 min at 4uC and resuspension in
SPG buffer [23]. The suspension was filtered twice through 5 mM
syringe filters and centrifuged at 13800 g for 15 min at 4uC.
Wolbachia-enriched pellets were resuspended in 1 mL of SPG
buffer and 300 ml carefully overlaid on each of three wells of C6/
36 cells grown in 12-well plates to ,80% confluence. Plates were
centrifuged for 1 h at 26uC, followed by overnight incubation and
cells passaged into fresh media the following day. Wolbachia
infection levels were checked after several passages using PCR and
FISH as above. Stable infection with wMelPop-CLA was achieved
within 6 passages and remained at ,100% throughout the course
of the experiments, as checked by FISH and cell counts. Cells were
routinely grown in RPMI 1640 (Invitrogen) supplemented with 1 x
Glutamax (Invitrogen) and 10% FBS and buffered with 25 mM
HEPES (Sigma-Aldrich). Stable infection with wMelPop-CLA was
achieved within 6 passages and remained at ,100% throughout
the course of the experiments, as checked by FISH and cell counts.
Wolbachia infection rates for both C6/36.wMelPop-CLA and
RML12.wMelPop-CLA cell lines were determined as the
proportion of cells displaying a fluorescent signal for the W2 and
W3 probes in FISH experiments. FISH experiments were
performed using 8-chambered slides, with 2 replicates of 100 cells
each inspected per chamber. Infection rates are given as average
percentages (6 standard error).
Determination of Wolbachia density by qPCR
Quantitative PCR (qPCR) was used to test for density
differences in Wolbachia between the C6/36.wMelPop-CLA and
RML12.wMelPop-CLA lines. DNA was extracted from five
biological replicate samples of 250,000 cells per cell line, using
the Qiagen DNAEasy kit (Qiagen). Two qPCR methods were
used: 1) relative quantification of the wsp gene versus a reference
mosquito gene RpS17 (Cook et al. 2007); and 2) absolute
quantification of the number of wsp gene copies per cell relative
to a known standard [8]. For the first method, separate qPCR
reactions were conducted for each gene, with each reaction
consisting of 5 ml of SYBR Greener master mix (Invitrogen), 5 ng
of DNA and 1 mM of primer in a final 10 ml volume as in [8].
Three technical replicates were performed for each of the five
biological replicates per each cell line. Wolbachia-gene to reference-
gene ratios were obtained following the method in [37]. For the
second method, a standard curve was created using a cloned wsp
gene fragment [8] with serially diluted known concentrations
assayed in parallel with the samples during the qPCR.
Cell proliferation assays
Cells were seeded in 96-well plates at 2610
4 cells/well and
allowed to attach for 3 hours. DENV-2 infected cells were
inoculated with virus at an MOI of 5, after which viral inoculum
was removed 2 h post-infection and cells grown in media
containing 2% FBS. Cell proliferation was assayed at 2, 4, 6 and
8 days post-infection virus using CellTiter 96H AQueous One
Solution (Promega) according to the manufacturer’s instructions.
Absorbance at 490 nm (directly proportional to amount of cell
proliferation) was read on a SpectraMax 250 plate reader.
Between 5–8 replicate wells were used for each cell line and day
of assay combination as well as for DENV uninfected controls.
Virus propagation and titration
The New Guinea C strain of DENV-2 was propagated for
experimental purposes in C6/36 cells grown in media as above but
supplemented with 2% FBS. Virus was harvested by collection of
supernatants 7 days post-infection and centrifugation at 3200 g for
15 min at 4uC. Virus stocks were stored at 280uC in single-use
aliquots and titrated on Vero cells using plaque assays. Briefly,
Vero cells were seeded in 96-well plates and grown at 37uCi na
humidified atmosphere with 5% CO2 in DMEM (Invitrogen)
supplemented with 5% FBS and 1 x Glutamax. At confluence,
cells were inoculated with virus and grown in Medium 199
(Invitrogen) containing 1% carboxymethylcellulose and supple-
mented with 2% FBS. Five days post-infection, cell monolayers
were washed with PBS, fixed with acetone/PBS, blocked for 1 h
and incubated for another hour with a primary antibody against
the DENV-2 NS1 protein (1:500). Monolayers were washed with
PBS, incubated for 1 h with a conjugated horseradish peroxidase
(1:500), followed by a final brief incubation with SIGMAFast DAB
(D0426, Sigma-Aldrich) until plaques became visible.
Experimental determination of DENV-2 replication
Viral replication experiments were performed using both pairs
of Wolbachia infected and uninfected cell lines, with each pair of
lines as a separate experiment. Cells were plated at 4610
5 cells/
well in 12-well plates and allowed to attach for 3 hours in media
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media at MOI of 0.1, 1 and 5. The viral inoculum was removed
2 h post-infection and cells were maintained in 2 mL of media
with 2% FBS. Viral harvests occurred at 2, 4, 6 and 8 days post-
infection, with supernatants from each well clarified from cells by
centrifuging for 10 min at 4000 g at 4uC and frozen at 280uC
until titration. Experiments were performed in triplicate wells for
each MOI, cell line (Wolbachia-infected or uninfected) and harvest
day combination. Titrations were performed in duplicate for each
supernatant using plaque assays.
Statistical analysis
Cell proliferation data for each pair of lines was analyzed as a
three-way ANOVA with presence/absence of Wolbachia, virus
infected/uninfected, day post-infection and their interactions. The
effects of Wolbachia and virus infection were also explored for each
day post-infection using two-way ANOVAs. To assess differences in
Wolbachia density between the C6/36.wMelPop and RML12.wMel-
Pop lines, gene expression ratio data obtained from qPCRs was
analyzed with a two-sample Wilcoxon rank sum test. We used two-
sample t-tests to detect statistically significant differences in the
absolute average density of Wolbachia between the two cell lines.
Plaque assay data from the RML12.Tet and RML12.wMelPop
cell lines was log-transformed to fit the assumptions of parametric
analyses. Three-way ANOVAs were initially performed with the
main factors presence/absence of Wolbachia, MOI, day post-
infection and their interactions. Since interactions were found to
be statistically significant (results not shown) thus rendering the
interpretation of main effects problematic, data was pooled across
MOIs within each day. Two-sample t-tests were performed on the
pooled data for each day to test for the effect of Wolbachia on viral
titer. Although plaque assay data obtained from the C6/36 and
C6/36.wMelPop lines was log-transformed it still strongly deviated
from normality. Results from a generalized linear model for non-
normal data indicated that the presence/absence of Wolbachia, the
day post-infection, MOI and the interaction between the three
factors had a significant effect on viral titer (results not shown).
Consequently, data was pooled across MOIs within days and
nonparametric Wilcoxon rank sum tests were performed for each
day to test for the effect of Wolbachia on viral titer. All analyses
were implemented in R [38].
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